Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enalapril for exercise capacity in severe COPD
2009-009074-27Phase 3Terminated
- Sponsor
- PROF. ALFREDO CHETTA
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Enalapril with Placebo (2 arms). Primary endpoints: Muscle strength and exercise capacity improvement and Muscle fiber type change. Started Mar 2009; status: terminated.
02
Drugs
enalapril
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2009-009074-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-009074-27.